PTC THERAPEUTICS, INC. — Director's Dealing 2021

Jan 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2021-01-06

Reporting Person: Hill Emily Luisa (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-06	Common Stock	A	10800	—	Acquired	24122	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-06	Stock Option (Right to Buy)	$66.49	A	63000	Acquired	2031-01-05	Common Stock (63000)	Direct

Footnotes

F1: Restricted stock units granted on January 6, 2021 that vest in four equal installments over four years, commencing on January 6, 2022.

F2: This option was granted on January 6, 2021, and vests over four years, with 25% of the shares underlying the option vesting on January 6, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 6, 2022.